2026 NPPES data Pharmacotherapy Pharmacist NPI 1396747192 PHARM.D., CDE
Verify on CMS →

JENNIFER GOLDMAN, PHARM.D., CDE

Pharmacotherapy Pharmacist in PEABODY, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
201
Medicare Part D claims · 24 beneficiaries · Pharmacotherapy Pharmacist avg: 397
Generic prescribing
33%
generic claims · 67% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: JENNIFER GOLDMAN, PHARM.D., CDE is a Pharmacotherapy Pharmacist ([object Object]) practicing in PEABODY, Massachusetts with a Medicare Part D prescribing footprint of 201 claims across 24 beneficiaries — 67% brand-name prescribing .

What stands out: JENNIFER GOLDMAN, PHARM.D., CDE filed 201 Medicare Part D claims in 2023 across PEABODY, Massachusetts. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

JENNIFER GOLDMAN, PHARM.D., CDE at a glance

Quality data not reported

NPI registry status

Active

Issued 08/11/2005

NPI 1396747192

Primary specialty

Pharmacotherapy Pharmacist

Mid-sized

5,925 US NPIs in this specialty

Medicare Part D claims

201 49% vs specialty avg

2023 prescription claims

Specialty avg: 397

Specialty distribution in Massachusetts

How Pharmacotherapy Pharmacist compares to other specialties among Massachusetts providers

Massachusetts providers

Pharmacotherapy Pharmacist share within Massachusetts

1. Pharmacotherapy Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacotherapy Pharmacist share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacotherapy Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacotherapy Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JENNIFER GOLDMAN, PHARM.D., CDE is a Pharmacotherapy Pharmacist provider practicing in PEABODY, Massachusetts, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARM.D., CDE. NPI: 1396747192. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

JENNIFER GOLDMAN, PHARM.D., CDE appears in the CMS NPPES registry as a Pharmacotherapy Pharmacist provider holding PHARM.D., CDE credentials at 2 1ST AVE, PEABODY, MA, 01960, with a listed phone of (978) 740-2300. NPI 1396747192 was issued on 08/11/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GOLDMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 201 prescription claims written by this provider, covering 24 Medicare beneficiaries and totaling roughly $133K in drug spend, split 67% brand-name and 33% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacotherapy Pharmacist is a mid-sized specialty nationwide, with 5,925 enrolled providers across 53 states and an average of 397 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2 1ST AVE
PEABODY, MA 01960

Provider Details

NPI 1396747192
Specialty Pharmacotherapy Pharmacist
Credentials PHARM.D., CDE
Gender Female
NPI Issued 08/11/2005

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to JENNIFER GOLDMAN, PHARM.D., CDE. To verify JENNIFER GOLDMAN, PHARM.D., CDE's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

JENNIFER GOLDMAN, PHARM.D., CDE — brand share 67.0%
Specialty average (est.)

67% brand-name claims vs 33% generic, on 201 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

201
Total Claims
$133K
Total Drug Cost
24
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
323
Total Day Supply
9,374
Brand vs Generic
67% brand / 33% generic
Brand Drug Cost
$127K

Patient Demographics

Average Patient Age
71.4 years
Avg HCC Risk Score
1.17

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Trulicity
Dulaglutide
42
Ozempic
Semaglutide
20

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacotherapy Pharmacist Overview

How JENNIFER GOLDMAN, PHARM.D., CDE fits within the Pharmacotherapy Pharmacist landscape nationally.

5,925
Pharmacotherapy Pharmacist Providers in US
53
States with Pharmacotherapy Pharmacist
397
Avg Claims per Provider

JENNIFER GOLDMAN, PHARM.D., CDE's 201 claims are below the specialty average of 397.

Nearby Pharmacotherapy Pharmacist Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as GOLDMAN.

Compare Pharmacotherapy Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is JENNIFER GOLDMAN, PHARM.D., CDE's specialty?
JENNIFER GOLDMAN, PHARM.D., CDE specializes in Pharmacotherapy Pharmacist and practices in PEABODY, Massachusetts. Credentials: PHARM.D., CDE.
How much does JENNIFER GOLDMAN, PHARM.D., CDE prescribe under Medicare Part D?
In 2023, JENNIFER GOLDMAN, PHARM.D., CDE wrote 201 Medicare Part D claims totaling $133K in drug costs for 24 beneficiaries.
Where is JENNIFER GOLDMAN, PHARM.D., CDE located?
JENNIFER GOLDMAN, PHARM.D., CDE is located at 2 1ST AVE, PEABODY, MA, 01960. Phone: (978) 740-2300.
What is JENNIFER GOLDMAN, PHARM.D., CDE's NPI number?
JENNIFER GOLDMAN, PHARM.D., CDE's National Provider Identifier (NPI) is 1396747192, issued on 08/11/2005.
Does JENNIFER GOLDMAN, PHARM.D., CDE prescribe more brand-name or generic drugs?
JENNIFER GOLDMAN, PHARM.D., CDE's prescribing is 67% brand-name and 33% generic drugs by claim count, with $127K in brand drug costs.
How many Pharmacotherapy Pharmacist providers are there in the US?
There are 5,925 Pharmacotherapy Pharmacist providers across 53 states in the US. The average Pharmacotherapy Pharmacist provider writes 397 Medicare Part D claims per year.
What drugs does JENNIFER GOLDMAN, PHARM.D., CDE prescribe most often?
Based on 2023 Medicare Part D data, JENNIFER GOLDMAN, PHARM.D., CDE's most frequently prescribed drugs include Trulicity, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JENNIFER GOLDMAN, PHARM.D., CDE accept Medicare?
JENNIFER GOLDMAN, PHARM.D., CDE appears in CMS Medicare data with 201 Part D claims and 24 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JENNIFER GOLDMAN, PHARM.D., CDE's credentials?
JENNIFER GOLDMAN, PHARM.D., CDE's NPI is 1396747192 with credentials PHARM.D., CDE. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology